DK1683522T3 - Benzoxaziner til forebyggelse eller behandling af hyperalgesi som induceres af morfinforbindelser - Google Patents

Benzoxaziner til forebyggelse eller behandling af hyperalgesi som induceres af morfinforbindelser

Info

Publication number
DK1683522T3
DK1683522T3 DK05292822T DK05292822T DK1683522T3 DK 1683522 T3 DK1683522 T3 DK 1683522T3 DK 05292822 T DK05292822 T DK 05292822T DK 05292822 T DK05292822 T DK 05292822T DK 1683522 T3 DK1683522 T3 DK 1683522T3
Authority
DK
Denmark
Prior art keywords
morphine
analgesic effect
hyper
alkyl
benzoxazines
Prior art date
Application number
DK05292822T
Other languages
English (en)
Inventor
Myriam Tirault
Bertrand Debaene
Guern Marie-Emmanuelle Le
Bernard Hublot
Original Assignee
Biocodex
Univ Poitiers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocodex, Univ Poitiers filed Critical Biocodex
Application granted granted Critical
Publication of DK1683522T3 publication Critical patent/DK1683522T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK05292822T 2005-01-06 2005-12-30 Benzoxaziner til forebyggelse eller behandling af hyperalgesi som induceres af morfinforbindelser DK1683522T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0500112A FR2880275B1 (fr) 2005-01-06 2005-01-06 Utilisation de composes pharmacologiques pour la prevention ou le traitement de la tolerance aigue aux morphiniques

Publications (1)

Publication Number Publication Date
DK1683522T3 true DK1683522T3 (da) 2009-01-12

Family

ID=34954620

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05292822T DK1683522T3 (da) 2005-01-06 2005-12-30 Benzoxaziner til forebyggelse eller behandling af hyperalgesi som induceres af morfinforbindelser

Country Status (9)

Country Link
US (1) US20060160789A1 (da)
EP (2) EP1987833A1 (da)
AT (1) ATE405267T1 (da)
DE (1) DE602005009126D1 (da)
DK (1) DK1683522T3 (da)
ES (1) ES2313254T3 (da)
FR (1) FR2880275B1 (da)
PL (1) PL1683522T3 (da)
PT (1) PT1683522E (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090093247A1 (en) * 2007-10-03 2009-04-09 Microsoft Corporation WWAN device provisioning using signaling channel
US8949434B2 (en) * 2007-12-17 2015-02-03 Microsoft Corporation Automatically provisioning a WWAN device
DK2512468T3 (da) 2009-12-15 2016-11-14 Hospital For Sick Children Fremgangsmåde til behandling af ar og beta-catenin-medierede sygdomme ved hjælp af neopam forbindelser
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
HRP20240278T1 (hr) * 2019-05-06 2024-05-10 Chemcom S.A. Upotreba kemijskog spoja i metode za suzbijanje neugodnog mirisa
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830803A (en) 1965-05-10 1974-08-20 Riker Laboratories Inc 5-loweralkyl-1-phenyl-1,3,4,6-tetrahydro-5h-benz(f)-2,5-oxazocines and 4-ones

Also Published As

Publication number Publication date
EP1683522B9 (fr) 2011-03-09
EP1683522A1 (fr) 2006-07-26
DE602005009126D1 (de) 2008-10-02
FR2880275A1 (fr) 2006-07-07
ES2313254T3 (es) 2009-03-01
PT1683522E (pt) 2008-11-20
EP1683522B1 (fr) 2008-08-20
PL1683522T3 (pl) 2009-04-30
FR2880275B1 (fr) 2007-04-13
EP1987833A1 (fr) 2008-11-05
ATE405267T1 (de) 2008-09-15
US20060160789A1 (en) 2006-07-20

Similar Documents

Publication Publication Date Title
DK1683522T3 (da) Benzoxaziner til forebyggelse eller behandling af hyperalgesi som induceres af morfinforbindelser
BRPI0308495B8 (pt) composto piridinoila útil para a ativação de receptores 5-ht1f, formulação farmacêutica, e, uso de um composto
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
AR037682A1 (es) Derivados de acetileno que tienen actividad antagonista para receptores glutamato metabotropico humanos, composicion farmaceutica, una combinacion y el uso de dichos derivados para la fabricacion de composiciones farmaceuticas
WO2006119507A3 (en) Non-nucleotide composition and method for inhibiting platelet aggregation
BRPI0607015A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto
EP1714961A4 (en) INDAZOL COMPOUND AND THEIR PHARMACEUTICAL USE
MA31084B1 (fr) Derives de piperidine agonistes de gpcr
BR122019017036B8 (pt) compostos de arilamidas substituídas por tetrazol, usos dos referidos compostos e composição farmacêutica
CR7928A (es) Medicamento para la profilaxis y el tratamiento de arteriosclerosis e hipertension
BR0314488A (pt) Composto, composição farmacêutica e métodos de tratamento
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
BRPI0518360A2 (pt) composto e sais farmaceuticamente aceitÁveis do mesmo, composiÇço farmacÊutica, uso de um composto, e, processo para preparar um composto ou um sal farmaceuticamente aceitÁvel do mesmo
WO2006014665A3 (en) Arylpyrrolidine derivatives as nk-1/ssri antagonists
BRPI0409211A (pt) composto, composição farmacêutica, métodos para ativar receptores 5-ht1f, para inibir extravasão de proteìna neuronial, e para o tratamento ou prevenção de enxaqueca em um mamìfero, e, uso de um composto
DE60113032D1 (de) Glucocorticoid Rezeptor Modulatoren
ATE539743T1 (de) Verfahren zur prävention und behandlung von ppar- vermittelten zuständen mit macelignan
ATE356621T1 (de) (s)-2-n-propylamino-5-hydroxytetralin als d3- agonistisches therapeutikum
BRPI0407097A (pt) Antagonista do casr
BRPI0507499A (pt) composto ou um sal farmaceuticamente aceitável ou hidrato dos mesmos, composição farmacêutica, uso do composto, e, métodos para tratar distúrbios mediados por mglur 5 e para inibir a ativação de receptores de mglur 5
DE60120077D1 (de) Modulatoren des Glucocorticoid-Rezeptors
WO2007105113A3 (en) Use of crf1 receptor antagonists for preparing a drug for treating metabolic syndrome and/or obesity and/or dyslipoproteinemia
BRPI0514892A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo
DK2076502T3 (da) Substituerede carboxamider som antagonister af gruppe-1 metabotrope receptorer
MY158069A (en) Tricyclic compound and pharmaceutical use thereof